Clinical Trial Update: Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating low-dose interleukin-2 in patients undergoing allogeneic hematopoietic stem cell transplantation to address graft-versus-host di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Hodgkin Lymphoma
• Myelodysplastic Syndromes
• Myeloproliferative Disorders
• Non-hodgkin Lymphoma

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Acute Lymphoblastic Leukemia, ALL | Phase 2 | Status: COMPLETED | Results posted: 2014-07-04